Folic acid modulates eNOS activity via effects on posttranslational modifications and protein-protein interactions

Eur J Pharmacol. 2013 Aug 15;714(1-3):193-201. doi: 10.1016/j.ejphar.2013.05.026. Epub 2013 Jun 21.

Abstract

Folic acid enhances endothelial function and improves outcome in primary prevention of cardiovascular disease. The exact intracellular signalling mechanisms involved remain elusive and were therefore the subject of this study. Particular focus was placed on folic acid-induced changes in posttranslational modifications of endothelial nitric oxide synthase (eNOS). Cultured endothelial cells were exposed to folic acid in the absence or presence of phosphatidylinositol-3' kinase/Akt (PI3K/Akt) inhibitors. The phosphorylation status of eNOS was determined via western blotting. The activities of eNOS and PI3K/Akt were evaluated. The interaction of eNOS with caveolin-1, Heat-Shock Protein 90 and calmodulin was studied using co-immunoprecipitation. Intracellular localisation of eNOS was investigated using sucrose gradient centrifugation and confocal microscopy. Folic acid promoted eNOS dephosphorylation at negative regulatory sites, and increased phosphorylation at positive regulatory sites. Modulation of phosphorylation status was concomitant with increased cGMP concentrations, and PI3K/Akt activity. Inhibition of PI3K/Akt revealed specific roles for this kinase pathway in folic acid-mediated eNOS phosphorylation. Regulatory protein and eNOS protein associations were altered in favour of a positive regulatory effect in the absence of bulk changes in intracellular eNOS localisation. Folic acid-mediated eNOS activation involves the modulation of eNOS phosphorylation status at multiple residues and positive changes in important protein-protein interactions. Such intracellular mechanisms may in part explain improvements in clinical vascular outcome following folic acid treatment.

Keywords: Endothelium; Folic acid; Kinase; Nitric oxide synthase; Phosphorylation; Vascular biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiotonic Agents / pharmacology*
  • Folic Acid / pharmacology*
  • Humans
  • Intracellular Space / drug effects
  • Intracellular Space / metabolism
  • Nitric Oxide Synthase Type III / metabolism*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation / drug effects
  • Protein Binding / drug effects
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinases / metabolism
  • Protein Processing, Post-Translational / drug effects*
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism
  • Swine

Substances

  • Cardiotonic Agents
  • Protein Kinase Inhibitors
  • Folic Acid
  • Nitric Oxide Synthase Type III
  • Protein Kinases
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt